Oncology News

Agenus Inc. , an immuno-oncology company developing a portfolio of checkpoint modulators , heat shock protein peptide-based vaccines, and adjuvants, today announced its financial results and business highlights for the second quarter ended June 30, 2014.

Bristol-Myers Squibb Co.' s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations.

Potential treatments for melanoma and other cancers will take shape in a laboratory at University of South Florida Research Park.

The U.S. Food and Drug Administration today approved Zydelig to treat patients with three types of blood cancers.

During National Cancer Survivors month June 2014, I had the pleasure of visiting The Breast Center at University of Maryland St. Joseph Medical Center.

You know how people toss around the phrase "the cure is worse than the disease"? They should meet Jim Olson.

Hayley Cook/WDNAmy Morgan, oncology patient navigator at the Appalachian Regional Hospital Regional Medical Center in Hazard, Kentucky demonstrates how the Skin Scope screening device is used.

The Children's Hospital of San Antonio has taken another step in its quest to develop a world-class pediatric cancer program.

During daylight hours, Dr David Robert Grimes takes on the serious and important job of battling cancer.

Mouse models of human oral cancer treated with an agent called capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, researchers from the School of Dentistry and School of Medicine at The University of Texas Health Science Center at San Antonio found.

Tawam Hospital, in affiliation with Johns Hopkins Medicine and part of the SEHA healthcare system, is hosting the third edition of the Emirates Oncology Conference and 14th Pan-Arab Cancer Congress from November 13 to 15, 2014 at the Emirates Palace hotel in Abu Dhabi.

The Molecular Oncology Diagnostics Laboratory will focus on breast, lung, melanoma and colorectal cancer patient samples when it first opens.

On friday afternoon mom was given some terrible news from her daughter. Her lab work came back abnormal & she told her oncologist that her back was hurting really bad.

The Nuffield Health Brighton Hospital was given a Macmillan Quality Environment Mark for offering high standards of care for people affected by cancer.

Local medical institutions work for your health Here is a list of the major medical institutions in the area.

But the brave Burdekin teen has refused to let her battle against an undiagnosed brain tumour hold her back from fighting for the lives of children with cancer.

Oliver Fetzer says that he may not have opted to bring his company, Cerulean Pharma, public in April had it not been for a discovery a few months earlier that showed his main cancer drug had one advantage he hadn't previously known anything about.

Pending data by year-end, we expect GILD to pay above fair value >100% upside for MGNX, reflecting its scarcity value delivering both immuno-oncology exposure and high-throughput drug development.

ROS1 fusion genes were successfully detected independent of gender or smoking history in young East Asian patients with lung adenocarcinoma , a histological subgroup in non-small cell lung cancer , using multiplex reverse transcriptase-polymerase chain reaction and immunohistochemistry diagnostic tests.

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.